Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma

http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=15744&path[]=50330

Daniel L. Pouliquen1,2,3, Béatrice Nawrocki-Raby4,5,6, Joëlle Nader1,2,3, Stéphanie Blandin2,7, Myriam Robard2,7, Philippe Birembaut4,5,6,8 and Marc Grégoire1,2,3

1 INSERM, UMR 1232, Nantes, France 2 Université de Nantes, Nantes, France 3 CNRS ERL, Nantes, France 4 INSERM, UMR-S 903, Reims, France 5 Université de Reims Champagne-Ardenne, Reims, France 6 SFR CAP-Santé, Reims, France 7 Plate-forme MicroPICell, SFR François Bonamy, Nantes, France 8 Laboratory of Biopathology, CHU Reims, Reims, France

Correspondence to:

Daniel L. Pouliquen, email: daniel.pouliquen@inserm.fr